Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,704 | 281,263 | 95,633 | 178,593 | 44,909 |
| Marketable Securities | 271,209 | 49,787 | 48,928 | 32,965 | N/A |
| Receivables | 607 | 805 | 15,503 | 18,354 | 9,453 |
| Inventories | 2,305 | 3,906 | 2,886 | 3,616 | 5,337 |
| TOTAL | $383,306 | $344,800 | $172,808 | $237,745 | $63,118 |
| Non-Current Assets | |||||
| PPE Net | 8,177 | 5,251 | 1,360 | 476 | 630 |
| Intangibles | 0 | 0 | 0 | 22,749 | 25,209 |
| Other Non-Current Assets | 26,982 | 5,133 | 6,188 | 2,402 | 2,760 |
| TOTAL | $35,159 | $10,384 | $7,548 | $25,627 | $28,599 |
| Total Assets | $418,465 | $355,184 | $180,356 | $263,372 | $91,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 10,475 | N/A | N/A |
| Accounts payable and accrued liabilities | 11,721 | 6,504 | 5,919 | 7,385 | 4,811 |
| Accrued Expenses | 18,103 | 17,521 | 16,359 | 14,422 | 8,445 |
| TOTAL | $49,048 | $63,263 | $34,537 | $23,658 | $14,888 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 29,310 | 36,562 | 37,977 |
| Deferred Revenues | 17,784 | 38,592 | 1,205 | 1,069 | 945 |
| Other Non-Current Liabilities | 22,063 | 4,906 | 6,584 | 4,212 | 4,695 |
| TOTAL | $32,916 | $25,598 | $49,451 | $55,334 | $58,288 |
| Total Liabilities | $81,964 | $88,861 | $83,988 | $78,992 | $73,176 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,729 | 49,831 | 34,302 | 34,044 | 28,741 |
| Common Shares | 68 | 49 | 34 | 34 | 18 |
| Retained earnings | -873,016 | -742,146 | -671,351 | -569,097 | -510,680 |
| Other shareholders' equity | 1,028 | 864 | 786 | 841 | 841 |
| TOTAL | $336,501 | $266,323 | $96,368 | $184,380 | $18,541 |
| Total Liabilities And Equity | $418,465 | $355,184 | $180,356 | $263,372 | $91,717 |